Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Tarek Besheer"'
Autor:
Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Tarek Besheer, Ahmed Elnakib, Ahmed Elhawary, Abdel-Hady El-Gilany, Hosam Zaghloul, Mohamed Elegezy
Publikováno v:
Journal of Advanced Research, Vol 54, Iss , Pp S5-S6 (2023)
Externí odkaz:
https://doaj.org/article/c4013004394049e6885e1a58a9e84d78
Autor:
Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Tarek Besheer, Ahmed Elhawary, Abdel-Hady El-Gilany, Hosam Zaghloul, Mohamed Elegezy, Ahmed Elnakib
Publikováno v:
Journal of Advanced Research, Vol 54, Iss , Pp S3-S4 (2023)
Externí odkaz:
https://doaj.org/article/be89e5b4e3d043b9bfc1b0f7a2f9ecfc
Publikováno v:
Egyptian Journal of Chest Disease and Tuberculosis, Vol 70, Iss 4, Pp 455-461 (2021)
Background Bronchial asthma is a heterogeneous disease, manifested by chronic airway-inflammatory changes. Viral hepatitis-C infection is a major worldwide illness with about 130–150 million that are chronically infected. Hepatitis-C virus (HCV) is
Externí odkaz:
https://doaj.org/article/b902feeb02194b77a9a89f41218b023b
Autor:
Mahmoud El-Bendary, Mustafa Neamatallah, Hatem Elalfy, Tarek Besheer, Emily Kamel, Hend Mousa, Abdel-Hamid Eladl, Maged El-Setouhy, Abdel-Hady El-Gilany, Ahmed El-Waseef, Gamal Esmat
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 68-77 (2019)
Introduction and aim. Hepatitis C virus (HCV) infection is a global medical problem. HLA -DRB1 alleles have an important role in immune response against HCV. The aim of this study is to clarify the contribution of HLA -DRB1 alleles in HCV susceptibil
Externí odkaz:
https://doaj.org/article/a21819ed310c4ea8afa988c890717e89
Autor:
Ahmed M. Abd El-Khalek, Nehal Tharwat Mohammed El-Sayed, Hatem Elalfy, Tarek Besheer, Khaled Farid, Mohamed ElAgezy, Wagdi Elkashef, Ahmed Alhawarey, Mahmoud El-Bendary, Ali Hasan Elmokadem
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 49, Iss 3, Pp 797-803 (2018)
Introduction: Percutaneous treatment of simple or hydatid liver cysts is widely used in clinical practice and ethanol is the commonest sclerosant used. Abdominal discomfort and pain commonly occurs after ethanol injection which increase with increase
Externí odkaz:
https://doaj.org/article/f8a8b8d081784c3c9223a9d385461f59
Publikováno v:
Egyptian Journal of Chest Disease and Tuberculosis, Vol 66, Iss 2, Pp 363-367 (2017)
Background: Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide and new drugs were licensed for its treatment. Quite a few studies worked on spectrum of respiratory side effects associated with those new the
Externí odkaz:
https://doaj.org/article/ea5b82fad957428f8dc08fda6fc29234
Publikováno v:
Egyptian Journal of Chest Disease and Tuberculosis, Vol 62, Iss 3, Pp 435-438 (2013)
Background: Spontaneous bacterial pleuritis is a high mortality complication in cirrhotic patients with hydrothorax. Aim: To investigate the prevalence and risk factors for spontaneous bacterial pleuritis in cirrhotic patients with hydrothorax. Metho
Externí odkaz:
https://doaj.org/article/2a8aab9336414d7fab8916760cc20344
Publikováno v:
Cells, Vol 7, Iss 11, p 185 (2018)
Chronic hepatitis C is implicated in insulin resistance (IR) susceptibility. An X-ray repair cross-complementing group 1 gene (XRCC1) is proposed to be a candidate gene for a study of IR susceptibility. So, this study aims to investigate the possible
Externí odkaz:
https://doaj.org/article/119ad20612bc448ba159598eed51f51b
Publikováno v:
Medical Journal of Viral Hepatitis. :32-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3197d6a9d75c39cd2160e36a60deed17
https://doi.org/10.21608/mjvh.2021.211711
https://doi.org/10.21608/mjvh.2021.211711
Autor:
Tamer Elhadidy, Mahmoud Abdel-Aziz Soliman, Abdel-Hady El-Gilany, Asem A. Hewidy, Tarek Besheer, Hossam Zaghloul, Mohamed Alegezy, Ahmed El-Mesery, Nermin Y Abo El Kheir, Douaa Raafat, Mahmoud El-Bendary, Hatem Elalfy, Ahmed Alhawarey, Wafaa M. El-Emshaty, Mustafa Neamatallah
Publikováno v:
Journal of Medical Virology
This trial compared the rate and time of viral clearance in subjects receiving a combination of nitazoxanide, ribavirin, and ivermectin plus Zinc versus those receiving supportive treatment. This non‐randomized controlled trial included 62 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdf3686e3f587a4f86da4384144c72ce
https://doi.org/10.1002/jmv.26880
https://doi.org/10.1002/jmv.26880